Sun Pharmaceutical Industries is currently trading at Rs. 791.45, up by 3.15 points or 0.40% from its previous closing of Rs. 788.30 on the BSE.
The scrip opened at Rs. 788.50 and has touched a high and low of Rs. 797.60 and Rs. 788.50 respectively. So far 24382 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 804.40 on 03-Aug-2021 and a 52 week low of Rs. 452.60 on 29-Oct-2020.
Last one week high and low of the scrip stood at Rs. 803.50 and Rs. 758.45 respectively. The current market cap of the company is Rs. 189427.50 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.47% and 12.05% respectively.
Sun Pharmaceutical Industries has sold Kayaku Co., a wholly-owned subsidiary of Sun Pharma Japan, a step-down subsidiary of the company. Sun Pharma Japan sold its entire shareholding in Kayaku Co. to Shinshin Pharmaceutical Co. (buyer) on September 1, 2021 for a total consideration of JPY 353,983,400. Thus Kayaku Co. has ceased to be the subsidiary of the company with effect from September 1, 2021.
The subsidiary company, Kayaku Co. whose entire shareholding is sold to the buyer comprised a factory at Tokorozawa and its related assets and liabilities. It is engaged in the business of manufacturing pharmaceutical products for external pharmaceutical companies. The other business of Kayaku Co. comprising the Saitama Factory and products manufactured thereat were carved out of Kayaku Co. with effect from September 1, 2021 and transferred to Sun Pharma Japan Technical Operations, a new subsidiary of Sun Pharma Japan set up for the purpose.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |